Humans352,623 participants13.6 yearsCohort study

Red Cell Distribution Width as an Independent Prognostic Biomarker in MASLD

Figure 1. Study flowchart and analytic cohort derivation.
Open the figure at full size
Figure 1. Study flowchart and analytic cohort derivation.Study flowchart and analytic cohort derivation.Ryu et al. · CC BY

Antioxidants

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) requires practical and inexpensive tools for risk stratification.

The paper

Soonchunhyang University · Catholic University of Korea

Antioxidants · 25 Aug 2026 · CC BY

doi.org/10.3390/antiox15091065PubMed 42792105

More on Metabolic dysfunction-associated steatotic liver disease